霍奇金淋巴瘤治疗的进步:从分子生物学到临床实践
Corrado Benevolo Savelli1, Matteo Bisio1, Luca Legato1
1Hematology Division, A.O.U. Città della Salute e della Scienza di Torino, C.so Bramante 88, 10126 Turin, Italy.
Cancers
|May 25, 2024
概括
经典霍奇金淋巴瘤 (cHL) 治疗已经推进了新型疗法,如布伦图西马布维多丁和检查点抑制剂,改善了复发患者的治疗结果. 未来的战略重点是免疫疗法和表观遗传点,以更好地治疗经典霍奇金淋巴瘤.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 经典霍奇金淋巴瘤 (cHL) 是高度可治愈的,但20%的患者在化疗后复发.
- 历史救援方案和自身干细胞移植正在被新型疗法所超越.
- 了解cHL生物学和瘤微环境的进步推动了新的治疗开发.
研究的目的:
- 审查最近在cHL生物学上的发现.
- 总结cHL的新和新兴治疗方案.
- 讨论cHL的未来治疗前景.
主要方法:
- 审查最近的临床试验和科学文献.
- 对针对cHL的新型治疗剂的分析.
- 探索免疫治疗和表观遗传策略.
主要成果:
- 布伦图西马布维多丁和PD-1/PD-L1抑制剂在复发性/耐火性cHL和前线设置中有效.
- 新兴疗法包括T细胞调节,CAR T细胞产品和表观遗传剂.
- 与PD-1阻断相结合的JAK2抑制显示出有希望的结果.
结论:
- 新型免疫疗法和向药物显著改善了cHL治疗结果.
- 对表观遗传机制和组合疗法的持续研究对未来充满希望.
- 针对古典霍奇金淋巴瘤的个性化治疗策略正在发展.
更多相关视频
15:07VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
Published on: December 28, 2015
26.7K
09:02Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
21.1K
相关概念视频
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
